ABUSCREEN RADIOIMMUNOASSAY FOR BENZODIAZEPINES— 510(k) K870994

Substantially Equivalent

Roche Diagnostic Systems, Inc.

FDA 510(k) clearance K870994 for ABUSCREEN RADIOIMMUNOASSAY FOR BENZODIAZEPINES, Substantially Equivalent on 1987-03-24. Applicant: Roche Diagnostic Systems, Inc..

Clearance details

Applicant: Roche Diagnostic Systems, Inc.
Product code: Code JXM
Advisory panel: Clinical Toxicology
Date received: 1987-03-11
Decision date: 1987-03-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Montclair, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.